Status: current, Defined. Date: 30-Nov 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1732531000168119 | emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1732541000168111 | emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | Is a | tenofovir alafenamide 25 mg tablet | true | Inferred relationship | Some | ||
| emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | Is a | medicinal product unit of use | false | Inferred relationship | Some | ||
| emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | Is a | emtricitabine + tenofovir alafenamide | true | Inferred relationship | Some | ||
| emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 1966582847 | |
| emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | has intended active ingredient | emtricitabine | true | Inferred relationship | Some | 1579136194 | |
| emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | has Australian BoSS | emtricitabine | true | Inferred relationship | Some | 1579136194 | |
| emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | has Australian BoSS | tenofovir alafenamide | true | Inferred relationship | Some | 1966582846 | |
| emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | has intended active ingredient | tenofovir alafenamide | true | Inferred relationship | Some | 1966582846 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| bictegravir 50 mg + emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | Is a | True | emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | Inferred relationship | Some | |
| emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet, 30 | has MPUU | True | emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | Inferred relationship | Some | 1 |
| Descovy 200/25 mg tablet | Is a | True | emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | Inferred relationship | Some | |
| emtricitabine 200 mg + rilpivirine 25 mg + tenofovir alafenamide 25 mg tablet | Is a | True | emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
Medicinal product unit of use reference set
FHIR